AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

28 recruiting trials

for Portal Vein Thrombosis

TACE Combined With ICIs Plus MTT After 125I Irradiation Stent Placement in HCC With Main PVTT. NCT06669377n/a1 site๐Ÿ“ Nanjing Zhongda Hospital IRE After Targeted Immunotherapy in HCC With Portal Vein Tumor Thrombus NCT07799922NA1 site๐Ÿ“ Tianjin Tianjin Medical University Cancer Institute and Hospital ยท Tests: IRE, PLACEBO Indicators Affecting PVT Recanalization NCT07473375n/a1 site๐Ÿ“ Shanghai Shanghai Zhongshan Hospital Atezolizumab Plus Bevacizumab Alone or Combined with External Beam Radiotherapy for HCC with Macrovascular Invasion NCT05992220Phase 21 site๐Ÿ“ Seoul Asan Medical Center ยท Tests: Atezolizumab plus bevacizumab, combined EBRT to vascular invasion, Atezolizumab plus bevacizumab PIVKA-II for Predicting Portal Vein Thrombosis in Hepatocellular Carcinoma NCT06960954n/a1 site๐Ÿ“ Tanta Tanta University ยท Tests: Prothrombin induced by vitamin K absence II (PIVKA-II) Radioembolization as a Spearhead Treatment of Hepatocellular Carcinoma With Localized Portal Vein Tumor Thrombosis NCT06166576Phase 25 sites๐Ÿ“ Ilsan๐Ÿ“ Seongnam-si๐Ÿ“ Seoul Seoul National University Hospital ยท Tests: Ablative radioembolization Perioperative Sintilimab Plus Bevacizumab Biosimilar and TACE-HAIC for HCC Patients With PVTT: A Phase-2 Clinical Trial NCT06031285Phase 21 site๐Ÿ“ Guangzhou Sun Yat-sen University ยท Tests: Sintilimab Freiburg TIPS Registry NCT05782556n/a1 site๐Ÿ“ Freiburg im Breisgau University Hospital Freiburg ยท Tests: Implantation of a transjugular intrahepatic portosystemic shunt (TIPS) BITS-TO-HCC Study: HAIC+Iparomlimab/Tuvonralimab + Bevacizumab + Surgery/SBRT for BCLC-C HCC With PVTT and/or Oligometastases NCT07062055Phase 21 site๐Ÿ“ Jinan Shandong Cancer Hospital and Institute ยท Tests: Anti-VEGF, Immunotherapy, Local Therapy, hepatic arterial infusion chemotherapy (HAIC), Surgical Resection Conversion Therapy With FOLFOX-HAIC Plus Lenvatinib And Tislelizumab For Hepatocellular Carcinoma With Vp3 Portal Vein Tumor Thrombus NCT07483359Phase 21 site๐Ÿ“ Shenyang First Hospital of China Medical University ยท Tests: HAIC + Tislelizumab +lenvatinib TIPS Plus Half-dose Donafenib in AHCC with PVTT-associated Portal Hypertension NCT06646198Phase 21 site๐Ÿ“ Guangzhou Fei Gao ยท Tests: Transjugular intrahepatic portosystemic shunt (TIPS), Donafenib The Impact on Survival of Neo-adjuvant Transarterial Chemoinfusion (TAI) for Patients With Hepatocellular Carcinoma And Portal Vein Tumor Thrombosis (PVTT) Who Underwent Hepatectomy : A Random, Controlled, Stage III Clinical Trial. NCT03368651Phase 31 site๐Ÿ“ Guangzhou Sun Yat-sen University ยท Tests: TAI Efficacy of Apixaban in the Treatment of Portal Vein Thrombosis Occurring More Than One Year After LS NCT07461545NA1 site๐Ÿ“ Yangzhou Northern Jiangsu People's Hospital ยท Tests: Apixaban 2.5 MG Apixaban-PK Trial: Preventing Portal Hypertension Complications in Cirrhosis NCT07521332Phase 41 site๐Ÿ“ Hyderฤbฤd Asian Institute Of Medical Sciences ยท Tests: Apixaban, Carvedilol, Placebo Efficacy of Apixaban in Treating Portal Vein Thrombosis Occurring More Than One Year After LSD NCT07461532NA1 site๐Ÿ“ Yangzhou Northern Jiangsu People's Hospital ยท Tests: Apixaban 2.5 MG Sintilimab Combined SBRT As Neoadjuvant Therapy for Resectable HCC with PVTT NCT06664996Phase 21 site๐Ÿ“ Chengdu West China Hospital ยท Tests: stereotactic body radiation therapy (SBRT), Sintilimab (approved) TACE Plus Atezolizumab/Bevacizumab and I-125 Seeds Brachytherapy for HCC With Branch PVTT NCT05984511NA1 site๐Ÿ“ Guangzhou Third Affiliated Hospital, Sun Yat-Sen University ยท Tests: I-125 Seeds Brachytherapy in PVTT, Transcatheter arterial chemoembolization, Atezolizumab plus Bevacizumab TIPS Combined With Lenvatinib and PD-1 Inhibitor for Advanced HCC With Main Trunk PVTT NCT06622031NA1 site๐Ÿ“ Beijing Sun Yat-sen University ยท Tests: Transjugular intrahepatic portosystemic shunt, Lenvatinib, PD-1 inhibitor SBRT With Immunotherapy and Atezo-Bev in HCC With Major Portal Vein Thrombosis NCT06823375Phase 22 sites๐Ÿ“ Hong Kong๐Ÿ“ Hong Kong Chinese University of Hong Kong ยท Tests: Radiotherapy, Atezolizumab plus Bevacizumab Early Transjugular Intrahepatic Portosystemic Shunt for Advanced Hepatocellular Carcinoma NCT06624098NA2 sites๐Ÿ“ Beijing๐Ÿ“ Beijing Sun Yat-sen University ยท Tests: Early TIPS Neoadjuvant IMRT Combined With Camrelizumab and Apatinib for Resectable HCC With PVTT NCT06349317Phase 21 site๐Ÿ“ Fuzhou Yongyi Zeng ยท Tests: Neoadjuvant intensity-modulated radiotherapy combined with perioperative camrelizumab and apatinib Lenvatinib Plus DEB-TACE and HAIC vs. Lenvatinib Plus DEB-TACE for Large HCC With PVTT NCT06492395Phase 31 site๐Ÿ“ Guangzhou Second Affiliated Hospital of Guangzhou Medical University ยท Tests: Len+DEB-TACE+HAIC, Len+DEB-TACE Lenvatinib, Sintilimab, and DEB-TACE With/Without HAIC for HCC >7 cm With PVTT NCT06904183Phase 21 site๐Ÿ“ Guangzhou Second Affiliated Hospital of Guangzhou Medical University ยท Tests: LEN+SIN+DEB-TACE+HAIC, LEN+SIN+DEB-TACE Iparomlimab and Tuvonralimab With Lenvatinib, Radiotherapy, and HAIC for Hepatocellular Carcinoma With Portal Vein Tumor Thrombus NCT07776080Phase 21 site๐Ÿ“ Wuhan Union Hospital, Tongji Medical College, Huazhong Universityโ€ฆ ยท Tests: Iparomlimab and Tuvonralimab (QL1706), Lenvatinib, Radiotherapy, hepatic arterial infusion chemotherapy (HAIC) QL1706 in Combination With Bevacizumab and RALOX HAIC for Hepatocellular Carcinoma With Vp3/4 PVTT NCT07327788Phase 21 site๐Ÿ“ Guangzhou Nanfang Hospital, Southern Medical University ยท Tests: Iparomlimab and Tuvonralimab Injection (QL1706), Bevacizumab, Hepatic Arterial Infusion Chemotherapy with Raltitrexed aโ€ฆ Efficacy & Safety of Anticoagulants in Cirrhosis ยฑ HCC NCT07132515Phase 41 site๐Ÿ“ Al Mansurah Mansoura University ยท Tests: Enoxaparin, warfarrin, or apixaban A Study of the Correlation Between Portal Vein Thrombosis and Prognosis of Liver Transplantation NCT06513780n/a1 site๐Ÿ“ Beijing Ru-zhou Cai ยท Tests: Observation Evaluation of SIRT Followed by Immunotherapy for Treatment of Hepatocellular Carcinoma With Portal Vein Thrombosis NCT07122089Phase 26 sites๐Ÿ“ Grenoble๐Ÿ“ Lille๐Ÿ“ Marseille Center Eugene Marquis ยท Tests: Selective Internal Radiotherapy, Tremelimumab, Durvalumab
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy